.Attribute Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin caused boosted progression-free and also total survival, triggering FDA commendation as well as a brand new therapy possibility for individuals.